SEC Form 4 · accession 0000899243-16-034017
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory A Gould
Director
Period of report
Nov 17, 2016
Accepted (ET)
Nov 21, 2016 · 4:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.68 | Nov 17, 2016 | A | 100,000 | A | — | Nov 17, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The option vests 25% on the date of grant and the remaining 75% in equal monthly installments over the next year.